Диссертация (1174214), страница 62
Текст из файла (страница 62)
– Vol.55. – P. 1318-1327.757. Vlachopoulos, C. The role of vascular biomarkers for primary and secondaryprevention. A position paper from the European Society of Cardiology Working Groupon peripheral circulation: Endorsed by the Association for Research into ArterialStructure and Physiology (ARTERY) Society / C. Vlachopoulos, P.
Xaplanteris,V. Aboyans et al. // Atherosclerosis. – 2015. – Vol.241(2). – P. 507-32.758. Vlassara, H. Role of oxidants/inflammation in declining renal function in chronickidney disease and normal aging / H. Vlassara, M. Torreggiani, J.B. Post et al. // KidneyInt. Suppl. – 2009. – Vol.76(114). – P. 3–11.759. Vogelzangs, N. Urinary cortisol and six-year risk of all-cause and cardiovascularmortality / N. Vogelzangs, A.T. Beekman, Y. Milaneschi et al. // J Clin Endocrinol Metab.– 2010. – Vol.95.
– P. 4959–4964.760. Völzke, H. Thyroid function and carotid wall thickness / H. Völzke, D.M.Robinson, U. Schminke et al. // J Clin Endocrinol Metab. – 2004. – Vol.89. – P. 21452149.761. von Zglinicki, T. Oxidative stress shortens telomeres / T. von Zglinicki // TrendsBiochem Sci. – 2002. – Vol.27. – P. 339 – 344.762. Vulliamy, T. The RNA component of telomerase is mutated in autosomal dominantdyskeratosis congenital / T. Vulliamy, A. Marrone, F.
Goldman et al. // Nature. – 2001. –Vol.413. – P. 432–435.342763. Vulliamy, T. Disease anticipation is associated with progressive telomereshortening in families with dyskeratosis congenita due to mutations in terc / T. Vulliamy,A. Marrone, R. Szydlo et al. // Nat Genet. – 2004. – Vol.36. – P. 447–449.764.
Wallace, D.C. Mitochondrial DNA mutations in disease and aging / D.C. Wallace// Env Mol Mutagenesis. – 2010. – Vol.51. – P. 440–450.765. Walldius, G. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronaryheart disease and targets for lipid-modifying therapy / G. Walldius, I. Jungner // J InternMed. – 2004.
– Vol.255. – P. 188–205.766. Walldius, J.I. High apolipoprotein B, low apolipoprotein A-I, and improvement inthe prediction of fatal myocardial infarction (AMORIS study): a prospective study / J.I.Walldius, I. Holme // Lancet. – 2001. – Vol.358. – P. 2026–33.767. Wang, M. Angiotensin II activates matrix metalloproteinase type II and mimics ageassociated carotid arterial remodeling in young rats / M.
Wang, J. Zhang, G. Spinetti etal. // The American journal of pathology. – 2005. – Vol.167. – P. 1429–1442.768. Wang, M. Central arterial aging: humans to molecules // Handbook ofHypertension: Arterial Stiffness in Hypertension //Elsevier. – 2006. – Vol. . – P. 137-160.769. Wang, M. Matrix metalloproteinase 2 activation of transforming growth factorbeta1 (TGFbeta1) and TGF-beta1-type II receptor signaling within the aged arterial wall/ M. Wang, D.
Zhao, G. Spinetti et al. //Arteriosclerosis, thrombosis, and vascularbiology. – 2006. – Vol.26. – P. 1503–1509.770. Wang, M. Proinflammatory profile within the grossly normal aged human aorticwall / M. Wang // Hypertension. – 2007. – Vol.50. – P. 219–227.771. Wang, M. Proinflammation: the key to arterial aging / M. Wang, L. Jiang, R.E.Monticone, et al. // Trends Endocrinol Metab. – 2014. – Vol.25(2). – P.
72-9.772. Wang, M. Altered regulation of matrix metalloproteinase-2 in aortic remodelingduring aging / M. Wang, E.G. Lakatta // Hypertension. – 2002. – Vol.39. – P. 865-73.773. Wang, M. Central arterial aging: humans to molecules. In: Safar M, editor.Handbook of hypertension: arterial stiffness in hypertension / Wang M., Lakatta E.G.
//Amsterdam: Elsevier. – 2006. – P. 137–60.343774. Wang, M.C. Stepwise increase in arterial stiffness corresponding with the stages ofchronic kidney disease / M.C. Wang, W.C. Tsai, J.Y. Chen et al. // Am J Kidney Dis. –2005. – Vol.45. – P. 494–501.775. Wang, T.J. Plasma natriuretic peptide levels and the risk of cardiovascular eventsand death / T.J. Wang, M.G. Larson, D. Levy et al.
// NEJM. – 2004. – Vol.350. – P. 655–663.776. Wang, Y.Y. Association of shorter mean telomere length with large artery stiffnessin patients with coronary heart disease / Y.Y. Wang, A.F. Chen, H.Z. Wang et al. // AgingMale. – 2011. – Vol.14. – P. 27–32.777. Wang, J. C. Aging and atherosclerosis: mechanisms, functional consequences, andpotential therapeutics for cellular senescence / J.
C. Wang, M. Bennett // Circ. Res. –2012. – Vol.111. – P. 245–259.778. Wassmann, S. Cellular antioxidant effects of atorvastatin in vitro and in vivo / S.Wassmann, U. Laufs, K. Müller et al. //ArteriosclerThrombVascBiol. – 2002. – Vol.22.– P. 300-5.779. Wautier, J.L.
Protein glycation: a firm link to endothelial cell dysfunction / J.L.Wautier, A.M. Schmidt // Circ Res. – 2004. – Vol.95. – P. 233–238.780. Weisbrod, R.M. Arterial stiffening precedes systolic hypertension in diet-inducedobesity / R.M. Weisbrod, T. Shiang, L. Al Sayah et al. // Hypertension.
– 2013. –Vol.62(6). – P. 1105-10.781. Weischer, M. Short telomere length, myocardial infarction, ischemic heart disease,and early death / M. Weischer, S.E. Bojesen, R.M. Cawthon et al. // Arterioscler ThrombVasc Biol. – 2012. – Vol.32. – P. 822–9.782. Weitzel, J.M. Coordination of mitochondrial biogenesis by thyroid hormone / J.M.Weitzel, K.A. Iwen // Mol Cell Endocrinol. – 2011. – Vol.342. – P.
1–7.783. Weng, N.P. Regulation of telomerase expression in human lymphocytes / N.P.Weng // Springer Semin. Immunopathol. – 2002. – Vol.24. – P. 23–33.784. Weng, N.P. Telomere and adaptive immunity / N.P. Weng // Mech. Ageing Dev. –2008. – Vol.129. – P. 60.344785. Wenisch, C. Circulating selectins, intercellular adhesion molecule-1, and vascularcell adhesion molecule-1 in hyperthyroidism / C. Wenisch, D. Myskiw, A. Gessl et al. //J Clin Endocrinol Metab. – 1995.
– Vol.80. – P. 2122-2126.786. Werner, C. Physical exercise prevents cellular senescence in circulating leukocytesand in the vessel wall / C. Werner, T. Fürster, T. Widmann et al. // Circulation. – 2009. –Vol.120. – P. 2438–2447.787. Werner, N. Intravenous transfusion of endothelial progenitor cells reducesneointima formation after vascular injury / N. Werner, S. Junk, U. Laufs et al. // Circ Res.– 2003. – Vol.93. – P. 17-24.788. Westerbacka, J.
Diminished wave reflection in the aorta: a novel physiologicalaction of insulin / J. Westerbacka, I. Wilkinson, T. Utriainen et al. // Hypertension. –1999. – Vol.33. – P. 1118–1122.789. Whitworth, J.A. Mechanisms of cortisol-induced hypertension in humans / J.A.Whitworth, M.A. Brown, J.J. Kelly et al. // Steroids. – 1995. – Vol.60. – P. 76–80.790.
Wikby, A. Expansions of peripheral blood CD8 T-lymphocyte subpopulations andan association with cytomegalovirus seropositivity in the elderly: the Swedish NONAimmune study / A. Wikby, B. Johansson, J. Olsson et al. // Exp. Gerontol. – 2002. –Vol.37. – P. 445.791. Wilkinson, I.B. Cholesterol, endothelial function and arterial stiffness / I.B.Wilkinson, J.R. Cockcroft // Curr Opin Lipidol. – 1998. – Vol.9.
– P. 237–442.792. Willeit, P. Cellular aging reflected by leukocyte telomere length predicts advancedatherosclerosis and cardiovascular disease risk / P. Willeit, J. Willeit, A. Brandstätter etal. // Arterioscler. Thromb. Vasc. Biol. – 2010. – Vol.30. – P. 1649–1656.793. Wilson,W.R. Blood leucocyte telomere DNA content predicts vascular telomereDNA content in humans with and without vascular disease / W.R. Wilson, K.E. Herbert,Y. Mistry et al.
// Eur Heart J. – 2008. – Vol.29. – P. 2689–2694.794. Wolach, B. Neutrophil chemotaxis, random migration, and adherence in patientswith hyperthyroidism / B. Wolach, B. Lebanon, A. Jedeikin et al. // Acta endocrinologica.– 1989. – Vol.121(6). – P. 817-20.345795. Wolkowitz, O.M. Leukocyte telomere length in major depression: Correlationswith chronicity, inflammation and oxidative stress—preliminary findings / O.M.Wolkowitz, S.H. Mellon, E.S. Epel et al. // PLoS ONE. – 2011. – Vol.6.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
